Cite
HARVARD Citation
Reynolds, C. et al. (n.d.). Initial testing (stage 1) of the phosphatidylinositol 3′ kinase inhibitor, SAR245408 (XL147) by the pediatric preclinical testing program1. Pediatric blood & cancer. 60 (5), pp. 791-798. [Online].